111536
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
热休克蛋白与植物化学物质在甲状腺结节消退中的相互作用解码：机制及治疗意义
Received 16 July 2025
Accepted for publication 22 November 2025
Published 13 December 2025 Volume 2025:19 Pages 11093—11105
DOI https://doi.org/10.2147/DDDT.S554080
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Anastasios Lymperopoulos
Ruina Zhang, Juanqin Lv
Department of Endocrinology, The Third Affiliated Hospital of Gansu University of Chinese Medicine, Baiyin, Gansu, People’s Republic of China
Correspondence: Juanqin Lv, Department of Endocrinology, The Third Affiliated Hospital of Gansu University of Chinese Medicine, Baiyin, Gansu, People’s Republic of China, Email 18089438271@163.com
Abstract: Thyroid nodules represent one of the most prevalent endocrine disorders, affecting up to 60% of adults worldwide, with diverse biological behaviors ranging from benign hyperplastic nodules to malignant thyroid carcinoma. Heat shock proteins (HSPs), especially HSP70 and HSP90, act as key molecular chaperones involved in cellular proliferation, stress tolerance, and survival, thereby contributing to both benign nodule persistence and malignant transformation. In parallel, phytochemicals such as curcumin, epigallocatechin gallate (EGCG), resveratrol, and quercetin have emerged as bioactive modulators capable of influencing HSP expression and activity. This review decodes the molecular crosstalk between HSPs and phytochemicals, elucidating how these natural compounds regulate signaling cascades including NF-κB, MAPK, and PI3K/Akt to mediate apoptosis, autophagy, and oxidative stress balance. Particular emphasis is placed on differentiating their therapeutic implications for benign nodule regression versus thyroid cancer inhibition. Preclinical evidence demonstrates that phytochemicals can downregulate HSPs, enhance apoptotic signaling, and sensitize tumor cells to therapy; however, clinical translation remains limited due to low bioavailability, off-target effects, and dosage optimization challenges. Addressing these pharmacokinetic and delivery barriers—through nanotechnology and precision-medicine-based approaches—may unlock new integrative strategies for thyroid disease management. Collectively, this review provides a mechanistic and translational framework highlighting HSP–phytochemical interactions as potential molecular targets for improving therapeutic outcomes in both benign and malignant thyroid pathologies.
Keywords: HSPs, phytochemicals, thyroid nodules, apoptosis and autophagy, signaling pathway modulation
Department of Endocrinology, The Third Affiliated Hospital of Gansu University of Chinese Medicine, Baiyin, Gansu, People’s Republic of China
Correspondence: Juanqin Lv, Department of Endocrinology, The Third Affiliated Hospital of Gansu University of Chinese Medicine, Baiyin, Gansu, People’s Republic of China, Email 18089438271@163.com
Abstract: Thyroid nodules represent one of the most prevalent endocrine disorders, affecting up to 60% of adults worldwide, with diverse biological behaviors ranging from benign hyperplastic nodules to malignant thyroid carcinoma. Heat shock proteins (HSPs), especially HSP70 and HSP90, act as key molecular chaperones involved in cellular proliferation, stress tolerance, and survival, thereby contributing to both benign nodule persistence and malignant transformation. In parallel, phytochemicals such as curcumin, epigallocatechin gallate (EGCG), resveratrol, and quercetin have emerged as bioactive modulators capable of influencing HSP expression and activity. This review decodes the molecular crosstalk between HSPs and phytochemicals, elucidating how these natural compounds regulate signaling cascades including NF-κB, MAPK, and PI3K/Akt to mediate apoptosis, autophagy, and oxidative stress balance. Particular emphasis is placed on differentiating their therapeutic implications for benign nodule regression versus thyroid cancer inhibition. Preclinical evidence demonstrates that phytochemicals can downregulate HSPs, enhance apoptotic signaling, and sensitize tumor cells to therapy; however, clinical translation remains limited due to low bioavailability, off-target effects, and dosage optimization challenges. Addressing these pharmacokinetic and delivery barriers—through nanotechnology and precision-medicine-based approaches—may unlock new integrative strategies for thyroid disease management. Collectively, this review provides a mechanistic and translational framework highlighting HSP–phytochemical interactions as potential molecular targets for improving therapeutic outcomes in both benign and malignant thyroid pathologies.
Keywords: HSPs, phytochemicals, thyroid nodules, apoptosis and autophagy, signaling pathway modulation